Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.
- 1 December 1983
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 80 (23) , 7200-7204
- https://doi.org/10.1073/pnas.80.23.7200
Abstract
Release of arachidonic acid by the membrane phospholipase and metabolism by the 5-lipoxygenase pathway was examined in human polymorphonuclear leukocytes (PMN). The 5-lipoxygenase pathway is activated when PMN are given arachidonic acid in ethanol and there is extensive metabolism to 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene B4 (LTB4). This activation event was altered by the ethanol because resting PMN given arachidonic acid with bovine serum albumin fail to metabolize arachidonic acid. Cells activated by the inflammatory agents N-formyl-Met-Leu-Phe (fMLF) or complement component C5a recruit the 5-lipoxygenase to metabolize exogenous arachidonic acid to 5-HETE and LTB4. When PMN were incubated with arachidonic acid-bovine serum albumin and challenged with fMLF or C5a (des-Arg-C5a) they produced 49-75 pmol of LTB4 and 310-440 pmol of 5-HETE per 107 cells. PMN stimulated by fMLF or C5a (des-Arg-C5a) do not induce membrane phospholipases to mobilize endogenous arachidonic acid and neither 5-HETE nor LTB4 is formed. PMN stimulation by the ionophore A23187 [calcimycin] activates both the membrane phospholipase and the 5-lipoxygenase to produce 5-HETE and LTB4 from endogenous arachidonic acid. The lipoxygenase pathway is apparently inoperative in resting PMN but can be recruited to chemotactic factors to act on arachidonate from extracellular sources. It was previously believed that the results refute the concept that formation of 5-HETE and LTB4 by the PMN depends solely on phospholipase to mobilize endogenous arachidonic acid and indicate that the role of phospholipase activation in PMN may be overestimated. Subsequent involvement of lipoxygenase products in mediating stimulation of PMN by inflammatory factors (e.g., as in aggregation and chemotaxis) remains in question unless an exogenous source of arachidonate can be identified.This publication has 29 references indexed in Scilit:
- Role of cell surface contact in the kinetics of superoxide production by granulocytes.Journal of Clinical Investigation, 1983
- 5, 8, 11, 14 - Eicosatetranoic acid (ETYA) inhibits binding of N-Formyl-methionly-leucyl-phenylalanine (FLMP) to its receptor on human granulocytesImmunopharmacology, 1982
- Leukotriene B4 — a stereospecific stimulator for release of lysosomal enzymes from neutrophilsFEBS Letters, 1981
- Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B.The Journal of Experimental Medicine, 1981
- Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.Journal of Clinical Investigation, 1980
- Inhibition of rabbit neutrophil lysosomal enzyme secretion, non-stimulated and chemotactic factor stimulated locomotion by nordihydroguaiaretic acidLife Sciences, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytesBiochemical Pharmacology, 1980
- Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.Proceedings of the National Academy of Sciences, 1978
- Initiation of phospholipase A2 activity in human platelets by the calcium ion ionophore A23187Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977